BMI1 and head and neck squamous cell carcinoma: Furthermore, BMI1, part of the polycomb group (PcG) proteins crucial for stem cell renewal [119], is targeted alongside cisplatin to synergistically suppress growth in head and neck squamous cell carcinoma (HNSCC) cells [120].